Working… Menu

Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer (FLIPPER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02690480
Recruitment Status : Active, not recruiting
First Posted : February 24, 2016
Last Update Posted : February 5, 2020
Information provided by (Responsible Party):
Spanish Breast Cancer Research Group

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 11, 2020
Estimated Study Completion Date : December 2023